Gene · 6036
Papers2,203
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,203
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Fecal Biomarkers of Neutrophil and Eosinophil Origin Reflect the Response to Biological Therapy and Corticosteroids in Patients With Inflammatory Bowel Disease. | Clin Transl Gastroenterol | 2023 | 37256716 | PubTator, text mining | PubMed |
| COVID-19-Associated Disease Course Is Shortened in Moderate-to-Severe Atopic Dermatitis Patients Receiving Dupilumab Treatment: A Retrospective Cross-Sectional Study. | J Clin Med | 2023 | 37240520 | PubTator, text mining | PubMed |
| Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis. | J Clin Med | 2023 | 37240477 | PubTator, text mining | PubMed |
| Eosinophil Granule Proteins Involvement in Acute Appendicitis-An Allergic Disease? | Int J Mol Sci | 2023 | 37240441 | PubTator, text mining | PubMed |
| Immunogenetics and pharmacogenetics of allergic asthma in Africa. | Front Allergy | 2023 | 37228580 | PubTator, text mining | PubMed |
| Eosinophilic granulomatosis with polyangiitis - Advances in pathogenesis, diagnosis, and treatment. | Front Med (Lausanne) | 2023 | 37215720 | PubTator, text mining | PubMed |
| Biomarkers for predicting type 2-high and uncontrolled asthma in real-world practice. | Ann Allergy Asthma Immunol | 2023 | 37209833 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective. | Mol Cell Proteomics | 2023 | 37209814 | PubTator, text mining | PubMed |
| New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis. | Clin Sci (Lond) | 2023 | 37199256 | PubTator, text mining | PubMed |
| Allergic sensitisation and type-2 inflammation is associated with new-onset and persistent allergic disease. | Clin Transl Allergy | 2023 | 37186426 | PubTator, text mining | PubMed |
| Delineating asthma according to inflammation phenotypes with a focus on paucigranulocytic asthma. | Chin Med J (Engl) | 2023 | 37185590 | PubTator, text mining | PubMed |
| The Role of Eosinophil-Derived Neurotoxin and Vascular Endothelial Growth Factor in the Pathogenesis of Eosinophilic Asthma. | Cells | 2023 | 37174726 | PubTator, text mining | PubMed |
| NET Proteome in Established Type 1 Diabetes Is Enriched in Metabolic Proteins. | Cells | 2023 | 37174719 | PubTator, text mining | PubMed |
| mRNA vaccines: a new opportunity for malaria, tuberculosis and HIV. | Front Immunol | 2023 | 37168860 | PubTator, text mining | PubMed |
| Inflammasome signaling proteins as biomarkers of COVID-19. | Front Immunol | 2023 | 37168848 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis for conducting a prognostic model and identifying immunotherapeutic targets in gastric cancer. | BMC Bioinformatics | 2023 | 37161430 | PubTator, text mining | PubMed |
| Identification of potential resistance mechanisms and therapeutic targets for the relapse of BCMA CAR-T therapy in relapsed/refractory multiple myeloma through single-cell sequencing. | Exp Hematol Oncol | 2023 | 37158921 | PubTator, text mining | PubMed |
| Antieosinophil Antibodies Alone or in Combination with Antineutrophil Cytoplasmic Antibodies (ANCA) Detected in Different Autoimmune Conditions. | J Immunol Res | 2023 | 37153639 | PubTator, text mining | PubMed |
| Cytokinopathy with aberrant cytotoxic lymphocytes and profibrotic myeloid response in SARS-CoV-2 mRNA vaccine-associated myocarditis. | Sci Immunol | 2023 | 37146127 | PubTator, text mining | PubMed |
| French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes. | Orphanet J Rare Dis | 2023 | 37122022 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6036/papers?page=12